Permanent alopecia following chemotherapy and bone marrow transplantation
Authors:
- 1 May 2000
- journal article
- case report
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 41 (2) , 106-108
Abstract
SUMMARY: Alopecia can be a psychologically daunting prospect for people requiring cancer chemotherapy. Fortunately, most patients experience only temporary hair loss. We report the case of a 23‐year‐old woman with chronic myeloid leukaemia who developed permanent, near‐total alopecia of her scalp, eyebrows, eyelashes, axillary and pubic hair following busulphan and cyclophosphamide chemotherapy which was used as conditioning prior to allogeneic bone marrow transplantation. The histology from a scalp biopsy revealed hair follicle destruction. Topical minoxidil failed to induce significant re‐growth.Keywords
This publication has 5 references indexed in Scilit:
- Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of TransplantationBlood, 1997
- Busulfan bioavailabilityBlood, 1994
- A comment on the law following the decision of the High Court of Australia in Rogers v. WhitakerMedical Journal of Australia, 1993
- Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesisCell, 1990
- AlopeciaCancer Nursing, 1984